Y a-t-il des complications liées aux traitements ?
Oui, les traitements peuvent entraîner des complications comme l'infection ou l'anémie.
Complications des traitementsInfectionAnémie
#4
Comment gérer les complications de la cocancérogenèse ?
La gestion implique un suivi médical régulier et des traitements symptomatiques.
Gestion des complicationsSuivi médicalTraitements symptomatiques
#5
Les complications peuvent-elles affecter la qualité de vie ?
Oui, les complications peuvent significativement altérer la qualité de vie des patients.
Qualité de vieComplicationsPatients
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque de cocancérogenèse ?
Les facteurs incluent le tabagisme, l'exposition à des produits chimiques et l'alcool.
Facteurs de risqueTabagismeProduits chimiques
#2
L'hérédité joue-t-elle un rôle dans la cocancérogenèse ?
Oui, des antécédents familiaux de cancer augmentent le risque de cocancérogenèse.
HéréditéAntécédents familiauxRisque de cancer
#3
Les infections peuvent-elles être un facteur de risque ?
Certaines infections, comme le HPV, sont des facteurs de risque connus pour le cancer.
InfectionsHPVFacteurs de risque
#4
Le mode de vie influence-t-il le risque de cocancérogenèse ?
Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque.
Mode de vieSédentaritéAlimentation
#5
L'exposition à la radiation est-elle un facteur de risque ?
Oui, l'exposition à des radiations ionisantes est un facteur de risque pour certains cancers.
RadiationsFacteurs de risqueCancers
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cocancérogenèse : Questions médicales les plus fréquentes",
"headline": "Cocancérogenèse : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cocancérogenèse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-05",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cocancérogenèse"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Carcinogenèse",
"url": "https://questionsmedicales.fr/mesh/D063646",
"about": {
"@type": "MedicalCondition",
"name": "Carcinogenèse",
"code": {
"@type": "MedicalCode",
"code": "D063646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Cocancérogenèse",
"alternateName": "Cocarcinogenesis",
"code": {
"@type": "MedicalCode",
"code": "D003043",
"codingSystem": "MeSH"
}
},
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Redefining Health Care Data Interoperability: Empirical Exploration of Large Language Models in Information Exchange.",
"datePublished": "2024-05-31",
"url": "https://questionsmedicales.fr/article/38819879",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/56614"
}
},
{
"@type": "ScholarlyArticle",
"name": "Building consensus on common features and interoperability use cases for community health information systems: a Delphi study.",
"datePublished": "2024-04-24",
"url": "https://questionsmedicales.fr/article/38663904",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjgh-2023-014001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Towards an Interoperability Landscape for a National Research Data Infrastructure for Personal Health Data.",
"datePublished": "2024-07-13",
"url": "https://questionsmedicales.fr/article/39003329",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41597-024-03615-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Making Science Computable Using Evidence-Based Medicine on Fast Healthcare Interoperability Resources: Standards Development Project.",
"datePublished": "2024-06-25",
"url": "https://questionsmedicales.fr/article/38916936",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/54265"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Evolution of Health Information Technology for Enhanced Patient-Centric Care in the United States: Data-Driven Descriptive Study.",
"datePublished": "2024-10-28",
"url": "https://questionsmedicales.fr/article/39466303",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/59791"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Processus néoplasiques",
"item": "https://questionsmedicales.fr/mesh/D009385"
},
{
"@type": "ListItem",
"position": 5,
"name": "Carcinogenèse",
"item": "https://questionsmedicales.fr/mesh/D063646"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cocancérogenèse",
"item": "https://questionsmedicales.fr/mesh/D003043"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cocancérogenèse - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cocancérogenèse",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cocancérogenèse",
"description": "Comment diagnostiquer la cocancérogenèse ?\nQuels tests sont utilisés pour évaluer la cocancérogenèse ?\nQuels signes cliniques peuvent indiquer une cocancérogenèse ?\nLa cocancérogenèse est-elle détectable par imagerie ?\nQuel rôle jouent les antécédents médicaux dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Health+Information+Interoperability#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cocancérogenèse",
"description": "Quels sont les symptômes associés à la cocancérogenèse ?\nLa cocancérogenèse provoque-t-elle des douleurs ?\nY a-t-il des symptômes spécifiques selon le type de cancer ?\nLes symptômes de cocancérogenèse sont-ils toujours visibles ?\nComment les symptômes évoluent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Health+Information+Interoperability#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cocancérogenèse",
"description": "Comment prévenir la cocancérogenèse ?\nLe dépistage précoce aide-t-il à prévenir la cocancérogenèse ?\nQuels aliments aident à prévenir la cocancérogenèse ?\nL'exercice physique joue-t-il un rôle dans la prévention ?\nLes vaccinations peuvent-elles prévenir la cocancérogenèse ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Health+Information+Interoperability#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cocancérogenèse",
"description": "Quels traitements sont disponibles pour la cocancérogenèse ?\nLa prévention est-elle un traitement pour la cocancérogenèse ?\nLes traitements varient-ils selon le type de cancer ?\nLa thérapie ciblée est-elle efficace contre la cocancérogenèse ?\nQuels sont les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Health+Information+Interoperability#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cocancérogenèse",
"description": "Quelles complications peuvent survenir avec la cocancérogenèse ?\nLa cocancérogenèse peut-elle entraîner des complications respiratoires ?\nY a-t-il des complications liées aux traitements ?\nComment gérer les complications de la cocancérogenèse ?\nLes complications peuvent-elles affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Health+Information+Interoperability#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cocancérogenèse",
"description": "Quels sont les principaux facteurs de risque de cocancérogenèse ?\nL'hérédité joue-t-elle un rôle dans la cocancérogenèse ?\nLes infections peuvent-elles être un facteur de risque ?\nLe mode de vie influence-t-il le risque de cocancérogenèse ?\nL'exposition à la radiation est-elle un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Health+Information+Interoperability#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la cocancérogenèse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la cocancérogenèse ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage, biopsies et analyses génétiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques peuvent indiquer une cocancérogenèse ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des lésions cutanées ou des anomalies cellulaires peuvent apparaître."
}
},
{
"@type": "Question",
"name": "La cocancérogenèse est-elle détectable par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à visualiser des tumeurs, mais pas la cocancérogenèse elle-même."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les antécédents médicaux dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'exposition à des agents carcinogènes sont cruciaux pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes associés à la cocancérogenèse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure fatigue, douleurs inexpliquées et changements de peau."
}
},
{
"@type": "Question",
"name": "La cocancérogenèse provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir en raison de tumeurs ou d'inflammation associée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques selon le type de cancer ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes varient selon le type de cancer lié à la cocancérogenèse."
}
},
{
"@type": "Question",
"name": "Les symptômes de cocancérogenèse sont-ils toujours visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains symptômes peuvent être asymptomatiques et nécessitent un dépistage."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver avec le temps si la cocancérogenèse progresse."
}
},
{
"@type": "Question",
"name": "Comment prévenir la cocancérogenèse ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les agents carcinogènes et adopter un mode de vie sain sont essentiels."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce aide-t-il à prévenir la cocancérogenèse ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce peut détecter des anomalies avant qu'elles ne deviennent cancéreuses."
}
},
{
"@type": "Question",
"name": "Quels aliments aident à prévenir la cocancérogenèse ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fruits, légumes et antioxydants peut réduire les risques."
}
},
{
"@type": "Question",
"name": "L'exercice physique joue-t-il un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut diminuer le risque de développer des cancers."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir la cocancérogenèse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancer."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la cocancérogenèse ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La prévention est-elle un traitement pour la cocancérogenèse ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les agents carcinogènes est une forme de traitement préventif."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type de cancer ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont adaptés en fonction du type de cancer et de son stade."
}
},
{
"@type": "Question",
"name": "La thérapie ciblée est-elle efficace contre la cocancérogenèse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie ciblée peut être efficace pour certains cancers liés à la cocancérogenèse."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure nausées, fatigue et immunosuppression."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la cocancérogenèse ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la progression du cancer et la métastase vers d'autres organes."
}
},
{
"@type": "Question",
"name": "La cocancérogenèse peut-elle entraîner des complications respiratoires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains cancers peuvent affecter la fonction pulmonaire et causer des complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications liées aux traitements ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des complications comme l'infection ou l'anémie."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications de la cocancérogenèse ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique un suivi médical régulier et des traitements symptomatiques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement altérer la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de cocancérogenèse ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'exposition à des produits chimiques et l'alcool."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans la cocancérogenèse ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer augmentent le risque de cocancérogenèse."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections, comme le HPV, sont des facteurs de risque connus pour le cancer."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque de cocancérogenèse ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à la radiation est-elle un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des radiations ionisantes est un facteur de risque pour certains cancers."
}
}
]
}
]
}
Efficient data exchange and health care interoperability are impeded by medical records often being in nonstandardized or unstructured natural language format. Advanced language models, such as large ...
This study aims to evaluate the capability of LLMs in transforming and transferring health care data to support interoperability....
Using data from the Medical Information Mart for Intensive Care III and UK Biobank, the study conducted 3 experiments. Experiment 1 assessed the accuracy of transforming structured laboratory results ...
The text-based approach showed a high conversion accuracy in transforming laboratory results (experiment 1) and an enhanced consistency in diagnostic code conversion, particularly for frequently used ...
This study highlighted the potential role of LLMs in significantly improving health care data interoperability, demonstrated by their high accuracy and efficiency in data transformation and exchange. ...
Information systems for community health have become increasingly sophisticated and evidence-based in the last decade and they are now the most widely used health information systems in many low-incom...
A Delphi study was conducted among a systematically selected panel of CHIS experts. This impressive pool of experts represented a range of leading global health institutions, with gender and regional ...
CHISs today are expected to adapt to a wide range of local contextual requirements and to support and improve care delivery. While once associated with a single role type (CHWs), these systems are now...
CHISs today are expected to be feature-rich, to support a range of user roles in community health systems, and to be highly adaptable to local contextual requirements. Future interoperability efforts,...
The German initiative "National Research Data Infrastructure for Personal Health Data" (NFDI4Health) focuses on research data management in health research. It aims to foster and develop harmonized in...
Evidence-based medicine (EBM) has the potential to improve health outcomes, but EBM has not been widely integrated into the systems used for research or clinical decision-making. There has not been a ...
This study aimed to introduce the EBM on Fast Healthcare Interoperability Resources (FHIR) project (EBMonFHIR), which is extending the methods and infrastructure of Health Level Seven (HL7) FHIR to pr...
As an ongoing process, the project creates and refines FHIR resources to represent evidence from clinical studies and syntheses of those studies and develops tools to assist with the creation and visu...
The EBMonFHIR project created FHIR resources (ie, ArtifactAssessment, Citation, Evidence, EvidenceReport, and EvidenceVariable) for representing evidence. The COVID-19 Knowledge Accelerator (COKA) pro...
EBMonFHIR resources in conjunction with other FHIR resources can support relaying EBM components in a manner that is interoperable and consumable by downstream tools and health information technology ...
Health information technology (health IT) has revolutionized health care in the United States through interoperable clinical care data exchange, e-prescribing, electronic public health reporting, and ...
This study aims to examine progress in health IT adoption and its alignment with the Office of the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health IT (ASTP's) m...
This study leverages data on end users of health IT to capture trends in engagement in interoperable clinical care data exchange (ability to find, send, receive, and integrate information from outside...
Since 2009, there has been a 10-fold increase in electronic health record (EHR) use among hospitals and a 5-fold increase among physicians. This enabled the interoperable exchange of electronic health...
Federal incentives have contributed to the widespread adoption of EHRs and broad digitization in health care, while efforts to promote interoperability have encouraged collaboration across health care...
Reaching meaningful interoperability between proprietary health care systems is a ubiquitous task in medical informatics, where communication servers are traditionally used for referring and transform...
In this study, a generic approach is developed, which allows for the application of declarative mapping rules defined using FML in an exchangeable manner. A transformation engine is required to execut...
FHIR natively defines resources to support the conversion of instance data, such as an FHIR StructureMap. This resource encodes all information required to transform data from a source system to a tar...
The resulting tool is called FML2Mirth, a Java-based transformer that derives Mirth channels from detailed declarative mapping rules based on the underlying StructureMaps. Implementation of the transl...
The tool for the auto-generation of Mirth channels was successfully presented. Our tests reveal the feasibility of using the complex structures of the mapping language in combination with a terminolog...
The lack of interoperability between health information systems reduces the quality of care provided to patients and wastes resources. Accordingly, there is an urgent need to develop integration mecha...
In accordance with the PRISMA guideline, a broad electronic search of all literature was conducted on the topic through six databases, including PubMed, Web of science, Scopus, MEDLINE, Cochrane Libra...
Interoperability has been raised in the field of health information systems from 2003 and now it is one of the topics of interest to researchers. The projects done in this field are mostly in the nati...
The health industry has become more complex and has new needs. Interoperability meets this needs by communicating between the output and input of processor systems and making easier to access the data...
Enabling widespread interoperability-the ability of health information technology systems to exchange information and to use that information without special effort-is a primary focus of public policy...
To assess primary care physician perspectives on the state of interoperability....
A cross-sectional survey of family medicine physicians in the US was conducted from December 12, 2021, to October 12, 2022. A sample of family medicine physicians who completed the Continuous Certific...
Eighteen items on the CCQ assessed experience accessing and using various information from outside organizations, including medications, immunizations, and allergies....
A total of 2088 physicians (1053 women [50%]; age reported categorically as either ≥50 years or <50 years) completed the CCQ interoperability questions in 2022. Of these respondents, 35% practiced in ...
This survey study of family medicine physicians found modest and uneven improvement in physicians' experience with interoperability. These findings suggest that substantial heterogeneity in satisfacti...
To review recent literature on health information exchange (HIE), focusing on the policy approach of five case study nations: the United States of America, the United Kingdom, Germany, Israel, and Por...
A narrative review of each nation's HIE policy frameworks, current state, and future HIE strategy....
Key themes that emerged include the importance of both central decision-making as well as local innovation, the multiple and complex challenges of broad HIE adoption, and the varying role of HIE acros...
HIE is an increasingly important capability and policy priority as electronic health record (EHR) adoption becomes more common and care delivery is increasingly digitized. While all five case study na...
High levels of seamless, bidirectional health information exchange continue to be broadly limited among provider groups despite the vast array of benefits that interoperability entails for patient car...
We aimed to examine the correlation at the provider group level between the distinct directions of interoperability with regard to sending health information and receiving health information, to descr...
We used data from the Centers for Medicare & Medicaid Services (CMS), which included interoperability performance information for 2033 provider groups within the Quality Payment Program Merit-based In...
We found that the examined directions of interoperability-sending health information and receiving health information-have relatively low bivariate correlation (0.4147) with a significant number of ob...
The adoption of interoperability by provider groups is more nuanced than traditionally considered and should not be seen as a binary determination (ie, to be interoperable or not). Asymmetric interope...
